Insulin Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: October 09, 2024 Report Code: GDME1843EPD-ST

Select Item

Insulin Delivery Pipeline Market Report Overview

Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below. The insulin delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Insulin Pumps

·       Patch Pumps

·       Insulin Pens

·       Insulin Pen Needles

·       Reusable Insulin Pens
Key Territories ·       The United States

·       Europe

·       China

·       India

·       Israel
Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       ICAC

·       PMA
Leading Companies ·       Abbott Diabetes Care Inc

·       Aerami Therapeutics Holdings Inc

·       AgVa Healthcare Pvt Ltd

·       Alshifa Medical Syringes Manufacturing Co Ltd

·       American Chemical Society
Enquire & Decide

Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Insulin Delivery Pipeline Market Segments

The key segments associated with the insulin delivery pipeline market are insulin pumps, patch pumps, insulin pens, insulin pen needles, and reusable insulin pens among others. As of October 2024, the insulin pumps had the highest number of insulin delivery pipeline products.

Insulin Delivery Pipeline Market Analysis by Segments, 2024 (%)

Insulin Delivery Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Insulin Delivery Pipeline Market
Download a Free Report Sample

Insulin Delivery Pipeline Market Segmentation by Territories

The key territories associated with the insulin delivery pipeline market are Europe, the United States, China, India, and Israel among others. As of October 2024, the US had the highest number of insulin delivery pipeline products.

Insulin Delivery Pipeline Market Analysis by Territories, 2024 (%)

Insulin Delivery Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Insulin Delivery Pipeline Market

Download a Free Report Sample

Insulin Delivery Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the insulin delivery pipeline products market are 510(k), CE, PMA, NMPA, and ICAC among others. As of October 2024, 510(k) was the most followed pathway for pipeline products in the insulin delivery market.

Insulin Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Insulin Delivery Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Insulin Delivery Pipeline Market

Download a Free Report Sample

Insulin Delivery Pipeline Market – Competitive Landscape

A few of the key companies associated with the insulin delivery pipeline market are Abbott Diabetes Care Inc., Aerami Therapeutics Holdings Inc., AgVa Healthcare Pvt Ltd, Alshifa Medical Syringes Manufacturing Co Ltd, and American Chemical Society among others.

Abbott Diabetes Care Inc: Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use.

Aerami Therapeutics Holdings Inc: Aerami Therapeutics Holdings Inc (Aerami), formerly Aerami Therapeutics Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients.

Key Companies in the Insulin Delivery Pipeline Market
Key Companies in the Insulin Delivery Pipeline MarketBuy the Full Report for More Company Insights into the Insulin Delivery Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Insulin Delivery Pipeline Market Segments Outlook (2024)

  • Insulin Pumps
  • Patch Pumps
  • Insulin Pens
  • Insulin Pen Needles
  • Reusable Insulin Pens

Insulin Delivery Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • China
  • India
  • Israel

Insulin Delivery Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • NMPA
  • ICAC
  • PMA

Scope

  • Extensive coverage of insulin delivery under development.

  • The report reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.

  • The report reviews the major players involved in the development of insulin delivery and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.

  • Identify and understand important and diverse types of insulin delivery under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Abbott Diabetes Care Inc
Aerami Therapeutics Holdings Inc
AgVa Healthcare Pvt Ltd
Alshifa Medical Syringes Manufacturing Co Ltd
American Chemical Society
AMF Medical SA
Amrita Vishwa Vidyapeetham
Andain, Inc
Animas Corp
ASTI Corp
Avecho Biotechnology Ltd
Becton Dickinson and Co
Bigfoot Biomedical Inc
Cambridge Consultants Ltd
Cellnovo Ltd (Inactive)
Companion Medical Inc
Debiotech SA
Defymed SAS
Dermisonics Inc
Diabeloop SA
Eli Lilly and Co
Embecta Corp
Emperra GmbH E-Health Technologies
EOFlow Co Ltd
Erech Finance Cahalacha Ltd
Glooko Inc
GO-Pen ApS
Harmonium Innovation SA
Hospira Inc
Houston Methodist Research Institute
Imagine Medical Device Inc.
InsuLenz
Insulet Corp
Iowa State University
Kailian Medical Technology Co Ltd
LifeScan Inc
Massachusetts Institute of Technology
Medical International Technologies (Mit Canada) Inc
MedPro Safety Products, Inc.
MedSolve Technologies, Inc.
Medtronic MiniMed Inc
Medtronic Plc
MicroPort Scientific Corp
MicroTech Medical Inc
Modular Medical Inc
Montmed Inc
NanoDerma Ltd
nGageIT Digital Health Inc
Nitto Denko Corp
North Carolina State University
Novo Nordisk AS
Open Medlabs Pvt Ltd
Pennsylvania State University
Perikinetics Inc
Pharmasens AG
Phluid Corporation
PhysioLogic Devices Inc
PositiveID Corp
Qlibrium Inc
Sanofi
SFC Fluidics LLC
Sooil Development Co., Ltd.
Spring Health Solutions Ltd.
Tandem Diabetes Care Inc
TempraMed Israel Ltd
Thermalin Inc
Transdermal Specialties Inc
University of KwaZulu-Natal
University of Limerick
University of Massachusetts Amherst
University of Missouri-Kansas City
University of North Carolina
University of Toronto
Univlabs Technologies Pvt Ltd
Valeritas Inc
ViCentra BV
Vigmed Holding AB
Washington University School of Medicine
Wayne State University
Ypsomed Holding AG
Zealand Pharma AS
Zenomics Inc

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Insulin Delivery Overview

3 Products under Development

3.1 Insulin Delivery – Pipeline Products by Stage of Development

3.2 Insulin Delivery – Pipeline Products by Segment

3.3 Insulin Delivery – Pipeline Products by Territory

3.4 Insulin Delivery – Pipeline Products by Regulatory Path

3.5 Insulin Delivery – Pipeline Products by Estimated Approval Date

3.6 Insulin Delivery – Ongoing Clinical Trials

4 Insulin Delivery – Pipeline Products under Development by Companies

4.1 Insulin Delivery Companies – Pipeline Products by Stage of Development

4.2 Insulin Delivery – Pipeline Products by Stage of Development

5 Insulin Delivery Companies and Product Overview

5.1 Abbott Diabetes Care Inc Company Overview

5.1.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Aerami Therapeutics Holdings Inc Company Overview

5.2.1 Aerami Therapeutics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 AgVa Healthcare Pvt Ltd Company Overview

5.3.1 AgVa Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.4 Alshifa Medical Syringes Manufacturing Co Ltd Company Overview

5.4.1 Alshifa Medical Syringes Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.5 American Chemical Society Company Overview

5.5.1 American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview

5.6 AMF Medical SA Company Overview

5.6.1 AMF Medical SA Pipeline Products & Ongoing Clinical Trials Overview

5.7 Amrita Vishwa Vidyapeetham Company Overview

5.7.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview

5.8 Andain, Inc Company Overview

5.8.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview

5.9 Animas Corp Company Overview

5.9.1 Animas Corp Pipeline Products & Ongoing Clinical Trials Overview

5.10 ASTI Corp Company Overview

5.10.1 ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview

5.11 Avecho Biotechnology Ltd Company Overview

5.11.1 Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.12 Becton Dickinson and Co Company Overview

5.12.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

5.13 Bigfoot Biomedical Inc Company Overview

5.13.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Cambridge Consultants Ltd Company Overview

5.14.1 Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.15 Cellnovo Ltd (Inactive) Company Overview

5.15.1 Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.16 Companion Medical Inc Company Overview

5.16.1 Companion Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 Debiotech SA Company Overview

5.17.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview

5.18 Defymed SAS Company Overview

5.18.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview

5.19 Dermisonics Inc Company Overview

5.19.1 Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 Diabeloop SA Company Overview

5.20.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview

5.21 Eli Lilly and Co Company Overview

5.21.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview

5.22 Embecta Corp Company Overview

5.22.1 Embecta Corp Pipeline Products & Ongoing Clinical Trials Overview

5.23 Emperra GmbH E-Health Technologies Company Overview

5.23.1 Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.24 EOFlow Co Ltd Company Overview

5.24.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.25 Erech Finance Cahalacha Ltd Company Overview

5.25.1 Erech Finance Cahalacha Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.26 Glooko Inc Company Overview

5.26.1 Glooko Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 GO-Pen ApS Company Overview

5.27.1 GO-Pen ApS Pipeline Products & Ongoing Clinical Trials Overview

5.28 Harmonium Innovation SA Company Overview

5.28.1 Harmonium Innovation SA Pipeline Products & Ongoing Clinical Trials Overview

5.29 Hospira Inc Company Overview

5.29.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview

5.30 Houston Methodist Research Institute Company Overview

5.30.1 Houston Methodist Research Institute Pipeline Products & Ongoing Clinical Trials Overview

5.31 Imagine Medical Device Inc. Company Overview

5.31.1 Imagine Medical Device Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.32 InsuLenz Company Overview

5.32.1 InsuLenz Pipeline Products & Ongoing Clinical Trials Overview

5.33 Insulet Corp Company Overview

5.33.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview

5.34 Iowa State University Company Overview

5.34.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview

5.35 Kailian Medical Technology Co Ltd Company Overview

5.35.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.36 LifeScan Inc Company Overview

5.36.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview

5.37 Massachusetts Institute of Technology Company Overview

5.37.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

5.38 Medical International Technologies (Mit Canada) Inc Company Overview

5.38.1 Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview

5.39 MedPro Safety Products, Inc. Company Overview

5.39.1 MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.40 MedSolve Technologies, Inc. Company Overview

5.40.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.41 Medtronic MiniMed Inc Company Overview

5.41.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview

5.42 Medtronic Plc Company Overview

5.42.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.43 MicroPort Scientific Corp Company Overview

5.43.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.44 MicroTech Medical Inc Company Overview

5.44.1 MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.45 Modular Medical Inc Company Overview

5.45.1 Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.46 Montmed Inc Company Overview

5.46.1 Montmed Inc Pipeline Products & Ongoing Clinical Trials Overview

5.47 NanoDerma Ltd Company Overview

5.47.1 NanoDerma Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.48 nGageIT Digital Health Inc Company Overview

5.48.1 nGageIT Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.49 Nitto Denko Corp Company Overview

5.49.1 Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview

5.50 North Carolina State University Company Overview

5.50.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

5.51 Novo Nordisk AS Company Overview

5.51.1 Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview

5.52 Open Medlabs Pvt Ltd Company Overview

5.52.1 Open Medlabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.53 Pennsylvania State University Company Overview

5.53.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview

5.54 Perikinetics Inc Company Overview

5.54.1 Perikinetics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.55 Pharmasens AG Company Overview

5.55.1 Pharmasens AG Pipeline Products & Ongoing Clinical Trials Overview

5.56 Phluid Corporation Company Overview

5.56.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.57 PhysioLogic Devices Inc Company Overview

5.57.1 PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

5.58 PositiveID Corp Company Overview

5.58.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview

5.59 Qlibrium Inc Company Overview

5.59.1 Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview

5.60 Sanofi Company Overview

5.60.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview

5.61 SFC Fluidics LLC Company Overview

5.61.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.62 Sooil Development Co., Ltd. Company Overview

5.62.1 Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.63 Spring Health Solutions Ltd. Company Overview

5.63.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.64 Tandem Diabetes Care Inc Company Overview

5.64.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview

5.65 TempraMed Israel Ltd Company Overview

5.65.1 TempraMed Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.66 Thermalin Inc Company Overview

5.66.1 Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview

5.67 Transdermal Specialties Inc Company Overview

5.67.1 Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview

5.68 University of KwaZulu-Natal Company Overview

5.68.1 University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview

5.69 University of Limerick Company Overview

5.69.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

5.70 University of Massachusetts Amherst Company Overview

5.70.1 University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview

5.71 University of Missouri-Kansas City Company Overview

5.71.1 University of Missouri-Kansas City Pipeline Products & Ongoing Clinical Trials Overview

5.72 University of North Carolina Company Overview

5.72.1 University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview

5.73 University of Toronto Company Overview

5.73.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview

5.74 Univlabs Technologies Pvt Ltd Company Overview

5.74.1 Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.75 Valeritas Inc Company Overview

5.75.1 Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview

5.76 ViCentra BV Company Overview

5.76.1 ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview

5.77 Vigmed Holding AB Company Overview

5.77.1 Vigmed Holding AB Pipeline Products & Ongoing Clinical Trials Overview

5.78 Washington University School of Medicine Company Overview

5.78.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview

5.79 Wayne State University Company Overview

5.79.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview

5.80 Ypsomed Holding AG Company Overview

5.80.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview

5.81 Zealand Pharma AS Company Overview

5.81.1 Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview

5.82 Zenomics Inc Company Overview

5.82.1 Zenomics Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Insulin Delivery- Recent Developments

6.1 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024

6.2 Sep 19, 2024: Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-Rapid Acting Insulin in European Union

6.3 Sep 18, 2024: Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology

6.4 Sep 13, 2024: Modular Medical Receives 510(K) Clearance For MODD1 (MODD Pivot)

6.5 Sep 09, 2024: Insulet Receives Additional FDA 510(k) Clearance for Omnipod 5 POD Delivery System

6.6 Sep 09, 2024: Eli Lilly Promotes Lucas Montarce to CFO

6.7 Sep 05, 2024: Embecta Receives 510(k) Clearance For Embecta Insulin Delivery System

6.8 Sep 05, 2024: Johnson & Johnson Appoints Christian Rodseth as North Asia Managing Director

6.9 Sep 04, 2024: Medtronic to Present New Data Regarding Use of the MiniMed 780G System Among Broader Population at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting

6.10 Sep 04, 2024: Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump

6.11 Sep 03, 2024: Embecta Announces FDA Clearance Of Its Disposable Patch Pump For Insulin Delivery Informed By The Unique Needs Of People With Type 2 Diabetes

6.12 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024

6.13 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.14 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.15 Aug 26, 2024: Omnipod 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

6.16 Aug 26, 2024: FDA Clears First Device To Enable Automated Insulin Dosing For Individuals With Type 2 Diabetes

6.17 Aug 26, 2024: Johnson & Johnson Taps New Chief Human Resources Officer

6.18 Aug 09, 2024: Biocon Q1 PAT Soars YoY to Rs 660 cr in FY25

6.19 Aug 08, 2024: Tandem Diabetes Care Receives Additional FDA 510(k) Clearance for Tandem Mobi Insulin Pump With Interoperable Technology

6.20 Aug 07, 2024: Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize

6.21 Jul 19, 2024: NuGen Receives Order for Repeat Demand in Mexico

6.22 Jul 15, 2024: Medtronic MiniMed Receives 510(K) Clearance For MiniMed Reservoir

6.23 Jul 15, 2024: Medtronic MiniMed Receives Additional 510(K) Clearance For Extended Reservoir

6.24 Jul 15, 2024: Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform

6.25 Jul 08, 2024: Net A Go Technology Announces Resignation or Executive Director and Appointment of Non-Executive Director

6.26 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings

6.27 Jun 24, 2024: Embecta-Sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps With 300U Insulin Reservoir

6.28 Jun 22, 2024: Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions

6.29 Jun 21, 2024: Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

6.30 Jun 20, 2024: Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

6.31 Jun 19, 2024: South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugs

6.32 Jun 18, 2024: Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions

6.33 Jun 13, 2024: Insulet Receives 510(K) Clearance For Omnipod 5 POD Delivery System

6.34 Jun 13, 2024: Adalvo Secures First EU Generic Approval for Liraglutide Pre-filled Pen

6.35 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.36 Jun 06, 2024: DEKA Research and Development Receives Additional 510(K) Clearance For DEKA ACE Pump System

6.37 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

6.38 May 31, 2024: Gan & Lee Pharmaceuticals’ Insulin Glargine Injection Prefilled Pen Approved in Mexico

6.39 May 29, 2024: Tandem Mobi Insulin Pump Now Compatible With Dexcom G7 Cgm

6.40 May 29, 2024: Gan & Lee Pharmaceuticals Pass the EMA Pre-Approval (GMP) Inspection

6.41 May 22, 2024: The Brazilian President attended the inauguration ceremony of Gan & Lee”s partner insulin factory

6.42 May 20, 2024: MiniMed 780G system recognized among Fast Company’s 2024 World Changing Ideas

6.43 May 20, 2024: Vanderbilt Researchers Receive $2 Million ARPA-H Contract to Improve Software Security in Medical Devices

6.44 May 16, 2024: Novo Nordisk’s Insulin Pen Shortage Impacts Thousands in South Africa

6.45 May 15, 2024: Pharmaceutical Giant Bayer AG Trims Workforce by 1500 Amid Slight Sales Decline

6.46 May 13, 2024: Novo Nordisk Plans Bond Sale to Fund Expansion

6.47 May 02, 2024: Novo Nordisk’s Sales Increased by 22% in Danish kroner and by 24% at Constant Exchange Rates to DKK

65.3 billion in the First Three Months of 2024

6.48 May 02, 2024: Adding AI to Artificial Pancreas Enhances Efficiency, Study Finds

6.49 May 01, 2024: MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024

6.50 Apr 30, 2024: Cristal Study Published in the Lancet Diabetes & Endocrinology Shows Promising Outcomes for Pregnant Women Living with Type 1 Diabetes

6.51 Apr 28, 2024: Insulin Shortages ‘Causing Stress and Anxiety’ for UK Diabetes Patients

6.52 Apr 26, 2024: Nitto Denko Announces Consolidated Financial Statements for the Year Ended March 31, 2024

6.53 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)

6.54 Apr 17, 2024: Droplet Micron Launches Expanded Indication and OTC Availability

6.55 Apr 16, 2024: Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results

6.56 Apr 12, 2024: Biotech Firms Genentech, Sanofi Laying off Hundreds at South San Francisco

6.57 Apr 11, 2024: Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

6.58 Apr 11, 2024: AstraZeneca Notice Result of AGM

6.59 Apr 04, 2024: Antitrust Watchdog FTC Probes Novo Nordisk Korea Over Needle Supply Cessation

6.60 Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

6.61 Apr 02, 2024: Tandem Diabetes Care Obtains Additional 510(K) Clearance For Tandem Mobi Insulin Pump With Interoperable Technology

6.62 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference

6.63 Mar 25, 2024: DEKA Research and Development Receives Additional FDA 510(k) Clearance for DEKA ACE Pump System

6.64 Mar 18, 2024: SPM Medicare Receives 510(K) Clearance For Insulin Syringe

6.65 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.66 Mar 08, 2024: Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod 5 Automated Insulin Delivery System Is Superior to Pump Therapy

6.67 Mar 07, 2024: Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023

6.68 Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029

6.69 Mar 06, 2024: embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

6.70 Mar 05, 2024: Insulet to Present Results From First Omnipod 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

6.71 Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes

6.72 Mar 04, 2024: Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX

6.73 Mar 04, 2024: Biden-Harris Administration Receives Counteroffers from Drug Companies as Part of Ongoing Negotiations to Lower Drug Prices

6.74 Feb 20, 2024: MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024

6.75 Feb 14, 2024: Tandem introduces automated insulin delivery system

6.76 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference

6.77 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference

6.78 Feb 13, 2024: Roche Confirms Product Development Team Layoffs

6.79 Feb 07, 2024: Insulet Announces CE Mark Approval of Omnipod 5 Integration With Abbott Freestyle Libre 2 Plus Sensor

6.80 Jan 24, 2024: Modular Medical Announces Issuance of New US Patent

6.81 Jan 22, 2024: Modular Medical submits MODD1 insulin pump for FDA clearance

6.82 Jan 18, 2024: Bayer to Cut Manager Jobs in Bid to Exit ‘Difficult Situation’

6.83 Jan 09, 2024: embecta Announces FDA 510(k) Submission for Insulin Patch Pump

6.84 Jan 08, 2024: Tandem Diabetes Care’s t:slim X2 Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre 2 Plus Sensor

6.85 Jan 04, 2024: Triple Jump Israel Receives 510(k) Clearance for Insulin Patch Pump

6.86 Jan 02, 2024: Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

6.87 Dec 28, 2023: Pfizer Announces Nearly 300 Layoffs Expected by in Rockland County

6.88 Dec 20, 2023: NuGen Medical signs InsuJet distribution deal in Belgium

6.89 Dec 14, 2023: Anhui Hongyu Wuzhou Medical Manufacturer Receives FDA 510(k) Clearance for Insulin Syringe

6.90 Dec 12, 2023: Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers

6.91 Dec 07, 2023: Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

6.92 Dec 06, 2023: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.

6.93 Dec 01, 2023: Retractable Technologies Not Impacted by FDA Safety Communication

6.94 Dec 01, 2023: No Embecta-Made Syringes Impacted by FDA Safety Communication

6.95 Nov 27, 2023: Unomedical A/S Recalls Varisoft Infusion Sets Due to Damage to the Connector Piece Causing Unexpected Disconnections

6.96 Nov 15, 2023: Tandem Diabetes Care Receives Additional 510(K) Clearance For T:slim X2 Insulin Pump With Interoperable Technology

6.97 Nov 15, 2023: Tandem Diabetes Care Receives 510(K) Clearance For t:slim X2 Control-IQ System – Adults

6.98 Nov 14, 2023: BD to Present at the 6th Annual Evercore ISI HealthCONx Conference

6.99 Nov 14, 2023: Modular Medical to Attend the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference

6.100 Nov 14, 2023: Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes

6.101 Nov 13, 2023: InsuJet Registered as a Medical Device in Mexico

6.102 Nov 02, 2023: Medline Industries Receives 510(K) Clearance For Safety Insulin and TB Syringe

6.103 Nov 02, 2023: Insulet Receives Additional 510(k) Clearance for Omnipod 5 ACE Pump

6.104 Oct 31, 2023: Modular Medical Updates Test Progress and Submission Timeline

6.105 Oct 26, 2023: Tandem Diabetes Care Receives Additional 510(K) Clearance For Tandem Mobi Insulin Pump With Interoperable Technology

6.106 Oct 26, 2023: Lilly to Participate in UBS Biopharma Conference 2023

6.107 Oct 20, 2023: Lilly Confirms Date and Conference Call for Third-Quarter 2023 Financial Results Announcement

6.108 Oct 10, 2023: Semaglutide – Ozempic(R) is Chemically Stable When Administered Using NuGen’s Needle Free InsuJet Device

6.109 Oct 10, 2023: Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023

6.110 Oct 09, 2023: Anhui Hongyu Wuzhou Medical Manufacturer Receives 510(k) Clearance for Insulin Pen Needle

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Insulin Delivery – Pipeline Products by Stage of Development

Insulin Delivery – Pipeline Products by Segment

Insulin Delivery – Pipeline Products by Territory

Insulin Delivery – Pipeline Products by Regulatory Path

Insulin Delivery – Pipeline Products by Estimated Approval Date

Insulin Delivery – Ongoing Clinical Trials

Insulin Delivery Companies – Pipeline Products by Stage of Development

Insulin Delivery – Pipeline Products by Stage of Development

Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview

Freestyle Libre Connected Insulin Pen – Product Status

Freestyle Libre Connected Insulin Pen – Product Description

Aerami Therapeutics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

Dance-501 – Product Status

Dance-501 – Product Description

AgVa Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Insul – Product Status

Insul – Product Description

Alshifa Medical Syringes Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

ALSHIFA Insulin Safety Syringe – Product Status

ALSHIFA Insulin Safety Syringe – Product Description

American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview

Mucoadhesive Insulin Patch – Product Status

Mucoadhesive Insulin Patch – Product Description

AMF Medical SA Pipeline Products & Ongoing Clinical Trials Overview

Sigi Patch Pump – Product Status

Sigi Patch Pump – Product Description

AMF Medical SA – Ongoing Clinical Trials Overview

Sigi Patch Pump – Sigi Insulin Management System – First-in-Human Study

Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview

Amrita Insulin Pump – Product Status

Amrita Insulin Pump – Product Description

Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview

Gaia Med Diamond Semi-Disposable Pump – Product Status

Gaia Med Diamond Semi-Disposable Pump – Product Description

Gemini Pump – Product Status

Gemini Pump – Product Description

Animas Corp Pipeline Products & Ongoing Clinical Trials Overview

Hypoglycemia-Hyperglycemia Minimizer System – Product Status

Hypoglycemia-Hyperglycemia Minimizer System – Product Description

ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview

Plastic Microneedle System – Product Status

Plastic Microneedle System – Product Description

Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview

TPM – Insulin Patch – Product Status

TPM – Insulin Patch – Product Description

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview

Smart Pen Needle – Product Status

Smart Pen Needle – Product Description

Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview

Bigfoot Certainty – Product Status

Bigfoot Certainty – Product Description

Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview

KiCoPen – Product Status

KiCoPen – Product Description

Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Wireless Insulin Pump System Integrated With inControl AP – Product Status

Wireless Insulin Pump System Integrated With inControl AP – Product Description

Companion Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Smart Insulin Pen – Advanced Decision Support – Product Status

Smart Insulin Pen – Advanced Decision Support – Product Description

Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview

JewelPump – Product Status

JewelPump – Product Description

JewelPUMP2 – Product Status

JewelPUMP2 – Product Description

Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview

ExOlin – Product Status

ExOlin – Product Description

Defymed SAS – Ongoing Clinical Trials Overview

ExOlin – An Open Label, Monocentric, Pilot Study Evaluating Safety of ExOlin in Patients with Poorly Controlled Type 1 Diabetes with High Glucose Fluctuations, Prone to Severe Hypoglycemia

Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview

U-Strip – Product Status

U-Strip – Product Description

Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview

DBL-4pen – Product Status

DBL-4pen – Product Description

Diabeloop SA – Ongoing Clinical Trials Overview

DBL-4pen – Multicentric Before/After Study to Assess the Efficacy and Safety of DBL-4pen Mobile Application on Glycemic Control in Patients With Type 2 Diabetes

Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview

AIR Insulin System – Product Status

AIR Insulin System – Product Description

Connected Care Pre-Filled Insulin Pen – Product Status

Connected Care Pre-Filled Insulin Pen – Product Description

Embecta Corp Pipeline Products & Ongoing Clinical Trials Overview

Closed-Loop Patch Pump with Insulin-Dosing Algorithm – Product Status

Closed-Loop Patch Pump with Insulin-Dosing Algorithm – Product Description

Extended Wear Insulin Infusion Set – Product Status

Extended Wear Insulin Infusion Set – Product Description

Open-Loop Insulin Patch Pump – Product Status

Open-Loop Insulin Patch Pump – Product Description

Tubed Patch Pump With T2D Insulin Control Algorithm – Product Status

Tubed Patch Pump With T2D Insulin Control Algorithm – Product Description

Tubeless Patch Pump With T2D Insulin Control Algorithm – Product Status

Tubeless Patch Pump With T2D Insulin Control Algorithm – Product Description

Embecta Corp – Ongoing Clinical Trials Overview

Closed-Loop Patch Pump with Insulin-Dosing Algorithm – A Randomized, Controlled, Crossover Trial to Assess a Fully Automated, Dual-hormone (Insulin-and-pramlintide) Delivery System Without Carbohydrate Counting in Regulating Glucose Levels in Adults With Type 1 Diabetes.

Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview

ESYSTA BT Pen – Product Status

ESYSTA BT Pen – Product Description

EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

EOPancreas System – Product Status

EOPancreas System – Product Description

EOPatch 3.0 – Product Status

EOPatch 3.0 – Product Description

Erech Finance Cahalacha Ltd Pipeline Products & Ongoing Clinical Trials Overview

Long Acting Insulin Therapy Device – Product Status

Long Acting Insulin Therapy Device – Product Description

Glooko Inc Pipeline Products & Ongoing Clinical Trials Overview

Insulin Dosing Algorithm – Connected Insulin Pens – Product Status

Insulin Dosing Algorithm – Connected Insulin Pens – Product Description

GO-Pen ApS Pipeline Products & Ongoing Clinical Trials Overview

GO-Pen – Product Status

GO-Pen – Product Description

Harmonium Innovation SA Pipeline Products & Ongoing Clinical Trials Overview

HARIT-IN139 – Product Status

HARIT-IN139 – Product Description

Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview

Integrated Symbiq/EndoTool System – Product Status

Integrated Symbiq/EndoTool System – Product Description

Houston Methodist Research Institute Pipeline Products & Ongoing Clinical Trials Overview

NICHE – Product Status

NICHE – Product Description

Imagine Medical Device Inc. Pipeline Products & Ongoing Clinical Trials Overview

Insulin Syringe – Product Status

Insulin Syringe – Product Description

InsuLenz Pipeline Products & Ongoing Clinical Trials Overview

Smart Polymer Contact Lens – Product Status

Smart Polymer Contact Lens – Product Description

Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview

Omnipod GO – Product Status

Omnipod GO – Product Description

Omnipod U-200 Insulin Management System – Product Status

Omnipod U-200 Insulin Management System – Product Description

Omnipod U-500 Insulin Management System – Product Status

Omnipod U-500 Insulin Management System – Product Description

Iowa State University Pipeline Products & Ongoing Clinical Trials Overview

Feed Forward Insulin Delivery System – Product Status

Feed Forward Insulin Delivery System – Product Description

Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

InnoPen Electric Insulin Pen – Product Status

InnoPen Electric Insulin Pen – Product Description

InnoTouch Insulin Application Pump – Product Status

InnoTouch Insulin Application Pump – Product Description

Le Pump Insulin Pump II – Product Status

Le Pump Insulin Pump II – Product Description

Lenomed ATA-I-1-0 Insulin Pump – Product Status

Lenomed ATA-I-1-0 Insulin Pump – Product Description

LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview

ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Status

ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Description

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Implantable Oxygen Generation Device – Product Status

Implantable Oxygen Generation Device – Product Description

Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview

Med-Jet MIT-P-I – Product Status

Med-Jet MIT-P-I – Product Description

MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Insulin Guard Self-Injector Safety Needle – Product Status

Insulin Guard Self-Injector Safety Needle – Product Description

MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Freehand Patch Pump – Product Status

Freehand Patch Pump – Product Description

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview

Insulin Delivery System – Product Status

Insulin Delivery System – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

EOPatch Wearable Insulin Pump System – Product Status

EOPatch Wearable Insulin Pump System – Product Description

Implantable Insulin Pump – Product Status

Implantable Insulin Pump – Product Description

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Angel Touch – Product Status

Angel Touch – Product Description

La Fenice Pen – Product Status

La Fenice Pen – Product Description

La Fenice V – Product Status

La Fenice V – Product Description

MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Equil Insulin Pump – Child and Adolescent Use – Product Status

Equil Insulin Pump – Child and Adolescent Use – Product Description

Second-Generation Patch Insulin Pump System – Product Status

Second-Generation Patch Insulin Pump System – Product Description

Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

MODD1 (MODD Pivot) – Product Status

MODD1 (MODD Pivot) – Product Description

MODD1+ – Product Status

MODD1+ – Product Description

Montmed Inc Pipeline Products & Ongoing Clinical Trials Overview

Sitesmart Coloured Pen Needles (CPN) – Product Status

Sitesmart Coloured Pen Needles (CPN) – Product Description

NanoDerma Ltd Pipeline Products & Ongoing Clinical Trials Overview

Intranasal Insulin Delivery Device – Product Status

Intranasal Insulin Delivery Device – Product Description

nGageIT Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview

InsuloSenz – Product Status

InsuloSenz – Product Description

Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview

PassPort Transdermal Basal Insulin Patch – 12 Hours – Product Status

PassPort Transdermal Basal Insulin Patch – 12 Hours – Product Description

PassPort Transdermal Basal Insulin Patch – 24 Hours – Product Status

PassPort Transdermal Basal Insulin Patch – 24 Hours – Product Description

North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview

Pulsatile Noninvasive Drug Delivery System – Product Status

Pulsatile Noninvasive Drug Delivery System – Product Description

Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview

AERx iDMS – Product Status

AERx iDMS – Product Description

LUMI Device – Product Status

LUMI Device – Product Description

SOMA Oral Device – Product Status

SOMA Oral Device – Product Description

Open Medlabs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

InsuFlo – Product Status

InsuFlo – Product Description

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview

Nanobot Based Insulin Pumping Device – Product Status

Nanobot Based Insulin Pumping Device – Product Description

Perikinetics Inc Pipeline Products & Ongoing Clinical Trials Overview

PK Insulin Delivery Conduit – Product Status

PK Insulin Delivery Conduit – Product Description

Pharmasens AG Pipeline Products & Ongoing Clinical Trials Overview

niia Advanced Pump System – Product Status

niia Advanced Pump System – Product Description

niia Essential Insulin Patch Pump System – Product Status

niia Essential Insulin Patch Pump System – Product Description

Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview

Ambulatory Diabetes Pump – Product Status

Ambulatory Diabetes Pump – Product Description

PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

ThinPump – Product Status

ThinPump – Product Description

PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview

Insulin Tracker – Product Status

Insulin Tracker – Product Description

Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview

QForma – Product Status

QForma – Product Description

Sanofi Pipeline Products & Ongoing Clinical Trials Overview

Fix-Flex Device – Product Status

Fix-Flex Device – Product Description

SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview

Dual ePump – Product Status

Dual ePump – Product Description

Open-Protocol Patch Pump System – Product Status

Open-Protocol Patch Pump System – Product Description

PANDA – Product Status

PANDA – Product Description

Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Dana-I Pump – Product Status

Dana-I Pump – Product Description

Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Spring Zone Hybrid Patch Pump – Product Status

Spring Zone Hybrid Patch Pump – Product Description

Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview

CSII Catheter – Product Status

CSII Catheter – Product Description

SteadiSet Infusion Set – Product Status

SteadiSet Infusion Set – Product Description

t:slim X3 Insulin Pump – Product Status

t:slim X3 Insulin Pump – Product Description

Tandem Mobi: Tubeless – Product Status

Tandem Mobi: Tubeless – Product Description

Tandem Patch – Product Status

Tandem Patch – Product Description

Tandem Diabetes Care Inc – Ongoing Clinical Trials Overview

CSII Catheter – A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue

SteadiSet Infusion Set – Open, Single Arm, Prospective, Multicenter Study of an Investigational Extended Wear Insulin Infusion Set During Home Use in People with Type 1 Diabetes

TempraMed Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview

VIVI Cap Smart – Product Status

VIVI Cap Smart – Product Description

Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview

Insulin Patch – Product Status

Insulin Patch – Product Description

Ultra-Rapid Highly-Concentrated Insulin Pump – Product Status

Ultra-Rapid Highly-Concentrated Insulin Pump – Product Description

Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview

U-Strip Insulin Patch – Product Status

U-Strip Insulin Patch – Product Description

University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview

Pectin Insulin Gel Skin Patch – Product Status

Pectin Insulin Gel Skin Patch – Product Description

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

Smart Gluco – Product Status

Smart Gluco – Product Description

University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview

Insulin Delivery System – Product Status

Insulin Delivery System – Product Description

University of Missouri-Kansas City Pipeline Products & Ongoing Clinical Trials Overview

Light Activated Insulin Depot – Product Status

Light Activated Insulin Depot – Product Description

University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview

Smart Insulin Patch – Product Status

Smart Insulin Patch – Product Description

Smart Insulin Patch – Product Status

Smart Insulin Patch – Product Description

University of Toronto Pipeline Products & Ongoing Clinical Trials Overview

Implantable Closed-Loop Insulin Delivery Device – Product Status

Implantable Closed-Loop Insulin Delivery Device – Product Description

Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

Wearable Insulin Patch Pump – Product Status

Wearable Insulin Patch Pump – Product Description

Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview

V-Go Prefill Device – Product Status

V-Go Prefill Device – Product Description

V-Go SIM – Product Status

V-Go SIM – Product Description

ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview

Kaleido Insulin Pump – Children And Adolescent – Product Status

Kaleido Insulin Pump – Children And Adolescent – Product Description

Vigmed Holding AB Pipeline Products & Ongoing Clinical Trials Overview

Insulin Needle – Product Status

Insulin Needle – Product Description

Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview

NICE Device – Product Status

NICE Device – Product Description

Wayne State University Pipeline Products & Ongoing Clinical Trials Overview

Subcutaneous Insulin Administration (SIA) Device – Product Status

Subcutaneous Insulin Administration (SIA) Device – Product Description

Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview

mylife YpsoPump 2.0 With Integrated CGM – Product Status

mylife YpsoPump 2.0 With Integrated CGM – Product Description

Servopen Zero – Product Status

Servopen Zero – Product Description

UnoPen Zero – Product Status

UnoPen Zero – Product Description

YpsoPod – Product Status

YpsoPod – Product Description

Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview

HyoPen – Product Status

HyoPen – Product Description

HypoPal Rescue Pen – Product Status

HypoPal Rescue Pen – Product Description

Zenomics Inc Pipeline Products & Ongoing Clinical Trials Overview

Smart Insulin Patch – Product Status

Smart Insulin Patch – Product Description

Glossary

Figures

Insulin Delivery – Pipeline Products by Stage of Development

Insulin Delivery – Pipeline Products by Segment

Insulin Delivery – Pipeline Products by Territory

Insulin Delivery – Pipeline Products by Regulatory Path

Insulin Delivery – Pipeline Products by Estimated Approval Date

Insulin Delivery – Ongoing Clinical Trials

Frequently asked questions

Insulin Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Insulin Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Insulin Delivery reports
Medical Devices
New
Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…
$7,500 | June 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Medical Devices
New
Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Insulin Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Insulin Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more